DV
Dividend Vision

TYRA — Tyra Biosciences, Inc.

Tyra Biosciences, Inc. (TYRA)

Total return is -2.7% over the past 4.9 years, 88.2 points behind SPY at 85.5%. Its deepest 1-year drawdown was 36.8%.

TYRA is an equity fund that focuses on biosciences holdings and has been operating since September 2021. The fund currently does not distribute dividends to shareholders, making it unsuitable for income-focused investors seeking regular payouts. This fund structure appeals primarily to growth-oriented investors seeking capital appreciation in the biosciences sector rather than those prioritizing dividend income.

TYRA key facts

Asset type
Stock
Asset class
Equity
Inception date
09/15/2021
Distribution frequency
None
Last close
$25.29
Market cap
$1,509,229,824
Average volume
420526.0
Beta
0.766
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.42